Turmeric and curcumin under regulatory scrutiny
Curcumin's bioavailability claims and rising global demand are drawing closer regulatory attention. What formulators need to watch as scrutiny increases across key markets.
What's inside
Curcumin's popularity has been built on bioavailability claims, and that is exactly where regulators are now looking hardest. This newsletter tracks the claims drawing scrutiny across the EU, US and Asia, the delivery formats most at risk, and what formulators should change before the rules tighten further.
Request early access to this newsletter
Fill in your details and we'll email it to you as soon as it's published.
Home
Our story, capacity and what makes Benova Healthcare a one-stop CDMO partner.
Product catalogue
Market-ready formulations across seven formats. Private label or custom.
Our process
Five integrated stages from formulation to delivery, all under one roof.
Quality & certifications
GMP-certified manufacturing, on-site laboratory testing and batch-level traceability.
About us
The team, the facility and the structural advantages behind our work.